Title:

Biodegradable Copolymer for Biomaterial Applications

Case # 119
Inventors: Matt Gevaert and Stephen Massia
Summary: Clemson University Bioengineering researchers have synthesized a covalently bonded polymer of poly (lactic acid) and dextran.  This synthetic approach results in a simpler, cleaner synthesis and a more biologically palatable polymer product with enhanced capacity for drug delivery.  The technique is applicable to a variety of polylactide: dextran ratios, resulting in polymers that can be either solids or hydrogels.  The incorporation of dextran modifies the degradation profile creating the ability to introduce dextran that has been loaded with other molecules.  Because of the range of properties of systems with different polylactide: dextran ratios, the synthesis would have to be optimized for a particular application.
Applications: Biodegradable polymers are used most commonly as implantable drug delivery devices and as scaffolds in tissue engineering applications.  The ability to covalently bond chemically active molecules such as drugs or cell-signaling peptides is key to achieving a desirable release profile and predicable effect on surrounding cells/tissue.  This copolymer would be useful in an application requiring a substrate for cell growth and/or biodegradative release of active molecules in a non-load bearing fashion.
Patent Status:

U.S. Patent #6,525,145 issued.

Licensing: Our interest is to identify interested industry parties to license the process and to collaborate with in its further development. 
Contact:

For more information about this technology, please contact:

Vincie Albritton, Associate Director
Phone: (864) 656-5708
Fax: (864) 656-0474
email: valbrit@clemson.edu

or 

Janet Dillon, Project Administrator
Phone: (864) 656-4237
Fax: (864) 656-0474
email: gjanet@clemson.edu

Note: Don't forget to include the technology number in your emails!